Rush CEO Dr. Larry Goodman to retire

Rush University System for Health CEO Dr. Larry Goodman will retire this summer, the academic health system announced late Wednesday. 

Dr. Ranga Krishnan, current dean of Rush Medical College and senior vice president of Rush University Medical Center, and Dr. Omar Lateef, the chief medical officer for the system and medical center, and senior vice president of medical affairs for the medical center, will split Goodman’s role. Krishnan will become CEO of the Chicago-based system, a three-hospital network anchored by Rush University Medical Center, and Lateef will become CEO of the medical center. 

Goodman has been CEO of Rush University Medical Center since February 2002 and assumed the role of CEO when the system was formed in March 2017. He informed the board about his retirement plans more than a year ago to kick off succession planning, said Goodman, who will turn 69 soon.

“Things are going well at Rush, I am fortunately healthy, I enjoy what I do, and I believe these kinds of transitions take time so I wanted to be purposeful in our succession planning,” Goodman told Modern Healthcare. “Some CEOs can stay too long or get sick and then not perform as well. I have been here my entire career and I care deeply about Rush, so I wanted to make sure I did the correct thing.”

Comparing Rush to other institutions, it would be hard to find another university, flagship hospital and medical system led by a single leader, said Susan Crown, chairman of the system and medical center boards. 

“We have grown substantially in all three areas,” she said. “Given our aspirations, it is important for each entity to have strong leadership and focus.” 

Rush has pushed several initiatives during Goodman’s tenure, two of which include boosting community outreach and revamping CMS’ hospital star ratings program. 

Rush spearheaded the West Side United program, a coalition of health systems, public institutions, residents and community groups formed in 2017. The group aims to address some of the root causes that have led to a 16-year discrepancy in life expectancy for some West Side residents from those in Chicago’s Loop. 

The academic health system has led dozens of informal “listening sessions” throughout the West Side to hear what residents need and learn how to appropriately intervene. Rush and West Side United are trying to spark a recovery through job training, local hiring and purchasing, small business funding and housing development. In the West Side and beyond, Rush looks to expand mental health services—particularly for military veterans— reduce gun violence and increase access to healthy food, among other initiatives.

Rush’s quality experts have been vocal about their criticism of the CMS’ star ratings. The agency’s statistical model unevenly weighted the eight measures in the safety-of-care group, which has skewed star ratings since they were first released in 2016, Rush argues. Quality experts contend that the latent variable modeling used in the calculations isn’t appropriate for measuring clinical outcomes and they are working with the CMS to adjust the formula. 

An infrastructure is in place to continue these efforts after his retirement, Goodman said. 

“It goes all the way up to the board,” he said.

Modern Healthcare’s sister publication, Crain’s Chicago Business, recently reported that Rush is exploring a merger with Swedish Covenant Health, which operates a one-hospital community health network in Chicago that includes a 150-member physician group and a managed care organization.

Rush nixed a merger with Chicago-based Little Company of Mary Hospital & Health Care Centers last year but has steadily grown its ambulatory network. More outpatient expansion is planned, executives said.

“We want to figure out how to get closer to the home and how to get new services in place outside of the traditional avenues of more clinics and more surgery centers,” said Krishnan, adding that Rush will look to build its own facilities as well as partner with both typical and atypical healthcare companies.

The academic health system is repaying more than $21 million to the federal government for alleged overpayment for inpatient and outpatient rehabilitation claims. 

Rush reported $94 million in operating income on revenue of $2.43 billion in 2018, up from $69.5 million in operating income on revenue of $2.27 billion in 2017, according to Modern Healthcare’s financial database. It had a 3.9% operating margin in 2018, up from 3.1% the year prior. 

Through the first half of its fiscal 2019, which started July 1, the academic health system posted a 1.9% operating margin and an adjusted $1.5 million operating loss related to early retirement payouts for certain employees. That compared to $47.2 million of adjusted operating income through the first six months of fiscal 2018.

Beth Israel Deaconess and Lahey Health complete merger

Beth Israel Deaconess Medical Center and Lahey Health officially combined to form Beth Israel Lahey Health, the second-largest health system in Massachusetts, the organizations announced Friday. 

In November, Massachusetts’ attorney general approved the deal with conditions including a seven-year price cap; participation in MassHealth, the state’s combined Medicaid and Children’s Health Insurance Program; and $71.6 million in investments supporting healthcare services for low-income and underserved communities in Massachusetts.

The price cap guarantees Beth Israel Lahey Health’s price increases will remain below the state’s annual healthcare cost growth benchmark of 3.1% for seven years. That will prevent more than $1 billion of the potential cost increases over a seven-year span projected by the Massachusetts Health Policy Commission, according to Attorney General Maura Healey.

Healey’s assurance of discontinuance does offer some flexibility amid “significant change in market conditions,” including significant swings in the consumer price index or new laws that significantly raise the cost of care. 

The Massachusetts Health Policy Commission, which has produced critical reports of the merger citing a potential to increase healthcare costs by up to $251 million per year, said it commends the conditions the attorney general placed on the deal that would help mitigate its concerns. They will have a real impact on access to treatment for mental health and substance-use disorders for patients across eastern Massachusetts, the commission said.

These types of regulations could become the new normal for hospital merger and pricing policy in the U.S., policy experts said. 

Between the Massachusetts Health Policy Commission and strong attorney general, Massachusetts has been fairly far out in front in terms of healthcare policy, said Zack Cooper, associate professor of health policy and economics at Yale University.

“What they are signaling with this settlement is that they will allow these sort of entities, conditional upon enforcing price regulation,” he said. “This is the de facto price and spending cap may become the norm in the next decade or so. Frankly, we face a choice of using a public option to put pressure on providers and insurers or simply regulate directly.” 

The industry is moving toward these types of monopolies that require price regulation, Cooper said. The challenge will be whether to regulate prices over the entire systems or only the overlapping sites. With the latter, the evidence shows that systems tend to shift the price increases to other sites in the system, he said.

“Capping prices for the entire system is a notable outcome of this ruling,” Cooper said. 

The merger includes Beth Israel in Boston and Lahey in Burlington, as well as Boston’s New England Baptist Hospital, Mount Auburn Hospital in Cambridge and Anna Jaques Hospital in Newburyport. 

Beth Israel Lahey Health operates a total of 10 hospitals as well as three affiliate hospitals in Cambridge Health Alliance, Lawrence General Hospital and Metrowest Medical Center. 

Its network includes four academic and teaching hospitals with affiliations with Harvard Medical School and Tufts University School of Medicine, eight community hospitals, specialty hospitals for orthopedics and behavioral health, and ambulatory and urgent care centers. It has a population health enterprise and a centralized network of administrative and operational services, executives said. 

“Through local and system partnerships, as well as the enthusiasm and talent of all our employees and providers, we will invest in and strengthen community-based care, informed by innovation and discovery,” Dr. Kevin Tabb, president and CEO of Beth Israel Lahey Health, said in prepared remarks.

The combined entity would have around $6 billion of revenue, more than 4,000 physicians and 35,000 employees.

Beth Israel and Lahey executives argued that their combination is necessary to heal a dysfunctional Massachusetts healthcare market that continues to overuse hospitals and academic medical centers. It’s the only way to check Partners, they said. Executives said they plan to expand the state’s now-limited behavioral health service network, helping divert patients from costly emergency departments. They pledged to use their combined purchasing power and expertise to lower costs, which they say will outpace any potential price increases.

Lahey Health narrowed its operating loss in 2018, but its expenses related to salaries and wages and supplies continued to rise. It reported a $29.6 million operating loss on revenue of $2.15 billion in 2018, compared to a $65.6 million operating loss on $2.03 billion in revenue in 2017.

CareGroup, which is the corporate parent of Beth Israel Deaconess, New England Baptist Hospital and Mount Auburn Hospital, reported $38.7 million of operating income on revenue of $3.53 billion in 2018, a significant increase from a $3.1 million operating loss on $3.33 billion of revenue in 2017.

Will blockchain save the healthcare system?

Blockchain 101

Blockchain is a log of activity that is time-stamped, tamper-proof and shared across a network of computers.

Originally dreamed up in 2009 by an unknown person or group—it’s not known for sure which—called Satoshi Nakamoto as a means to move the digital currency bitcoin, its uses have since been broadened to exchange other types of digital assets, such as data, in private, permissioned networks suitable for businesses.

Each transaction that goes into the log of activity is enclosed in a block and linked together in chronological order to form a chain, giving it the name blockchain.

Blockchain is gaining traction as a tool that could help solve some of the healthcare industry’s age-old problems that have resulted in wasteful spending and higher costs for providers, insurers and patients. Once-reluctant competitors are joining forces to find out just what the technology can do and in the process are developing new transparent business models. 

A senior distinguished engineer at the healthcare services company Optum, had been experimenting with how to solve healthcare industry problems with that emerging, exciting, little understood technology called blockchain. He had heard rumors that health insurer Humana, like Optum, had been testing blockchain’s applications.

So during lunch at the Distributed Health conference in September 2017, Jacobs and Humana Lead Enterprise Architect Kyle Culver described their projects in careful terms (there was no nondisclosure agreement in place) and learned that both companies were attempting to use blockchain to improve the accuracy of healthcare provider directories—a perennial, costly issue for the insurance industry. Their experiments had revealed that blockchain works best when multiple partners are involved.

Just two months later, Optum, Humana and three others—MultiPlan, Quest Diagnostics and Optum’s corporate sibling UnitedHealthcare—had solidified an agreement to form the Synaptic Health Alliance, which in June 2018 piloted the use of blockchain to fix errors in provider directories and lower the cost of keeping that information up to date by sharing the data and workload. Aetna and health system Ascension have since joined the group. With “multiple people looking at the same information, the quality of that information should go up and operational costs for the provider and the payers should go down because there’s less-frequent contact being done between those two stakeholders. And because the quality goes up there should be a better experience for the patient,” Jacobs said.

It’s early, but the companies have already found they are able to locate inaccurate information faster than they would on their own while also protecting information from cyberattacks. The goal is to scale the tool to a national level. But fixing provider directories is an initial foray. “We have a general agreement that, boy, if we can get this to work, this is just the first area of focus,” Jacobs said.

They anticipate that blockchain will be the key that unlocks barriers to healthcare data-sharing and ultimately enables an industrywide shift to value-based care.

“When we talk about healthcare today, we talk about the silos a lot—the silos of data and the barrier for exchanging information,” Humana’s Culver explained. “The hope is that blockchain allows us to connect those silos and … enable new capabilities (so that) access to information no longer is where we compete, but we compete much more on the value-added service and the trust and transparency of the companies that are providing those things.” 

In the simplest terms, blockchain is a shared record of transactions. It enables participants in a group to securely share data with each other without a middleman and keep track of what was exchanged and when. Instead of that record being located on a single, hackable computer, it is maintained across multiple computers, which makes the information extremely difficult to tamper with or delete. That tamper-proof characteristic, along with a process that ensures any information put into the blockchain is valid, enables trust between the group participants.

So in the case of the blockchain-enabled provider directory, if one insurance company in the alliance calls a doctor’s office to verify an address and updates that information in the record, all members of the alliance would see the change. That means less work for the rest of the insurers and the doctor’s office.

Unnecessary ED visits from chronically ill patients cost $8.3 billion

About 30% of emergency department visits among patients with common chronic conditions are potentially unnecessary, leading to $8.3 billion in additional costs for the industry, according to a new analysis.

The report, released Thursday by Premier, found that six common chronic conditions accounted for 60% of 24 million ED visits in 2017; out of that 60%, about a third of those visits—or 4.3 million—were likely preventable and could be treated in a less expensive outpatient setting.

The frequency of unnecessary ED visits from the chronically ill is unsurprising given the fee-for-service payment environment the majority of providers remain in, said Joe Damore, senior vice president of population health consulting at Premier. On average, only 10% of providers’ payment models are tied to value-based models, he said, so providers don’t have an incentive to effectively manage patients to prevent disease progression and promote wellness.

Premier’s findings are in line with other research on patients with chronic diseases, finding they are more likely to use the ED and get admitted to hospitals because they experience poor care coordination. 

“Value-based care is managing a chronically ill patient in a coordinated way, and the traditional payment model hasn’t rewarded that. It’s episodic,” Damore said. 

The six chronic conditions used in the analysis are asthma, chronic obstructive pulmonary disease, diabetes, heart failure, hypertension and behavioral health conditions, such as mental health or substance abuse issues. They were selected because they are often cited in the academic literature as the most common and costly conditions in the healthcare system, Premier said. 

The data from the 24 million ED visits at 747 hospitals comes from Premier’s database, which has information on 45% of U.S. patient discharges, according to Premier. To get the results, Premier identified hospitals with the lowest quartile visit rate, or those that had the lowest ED admission rates by condition, and calculated how many visits at the remaining hospitals could be prevented if all hospitals achieved those rates for the six chronic conditions. 

And then to arrive at the $8.3 billion in costs, Premier used the average cost for an ED visit estimated by the Health Care Cost Institute, which is $1,917. 

Damore said that although the industry is “mostly fee-for-service at this time,” he expects an eventual transition to value. “More and more providers are convinced that the future is going to be value-based payment,” he said.

Five Reasons Why Patient Data Privacy and Control is so Important by Dr. Moira Schieke

The ancient Greek father of medicine, Hippocrates, knew that trust was a fundamental tenet for the effective practice of medicine.  How can a patient seek the care of a stranger without the establishment of a fiduciary trust?  A patient must reveal the most personal, private information about themselves and therefore must possess the utmost confidence in their physician to keep their information in confidence and all uses of their data transparent.  Yet, in today’s digital social media age, does privacy really exist?  Large companies make unfathomable fortunes harvesting all manner of data from financial information to the mundane minutia of daily life.  In this environment, here are five reasons why patient data privacy and control are more important than ever:

1.  Maintain the fundamental fiduciary doctor-patient relationship.

            “Things that are holy are revealed only to men who are holy.”  – Hippocrates, Greek physician (460 BC – 377 BC)

It is critical for the health care system to maintain the trust between doctor and patient in a patient-centric dynamic.  If patients believe that information they give their doctors and healthcare professionals, and by extension, these larger institutions is going to be used against them and not in the patient’s best interest, then patients will be reticent to provide needed details for their own health and well-being thus deteriorating their own healthcare.  If patients believe in the ultimately altruistic interests of their doctors, they will be more likely to provide critical details and take an active role in their care.  In addition, there is great financial pressure to utilize algorithms to automate care decisions to reduce costs, thereby increasing institutional and industry profits.  The doctor-patient relationship prevents direct access of industry-designed algorithms that could work more in the interest of industry profits, rather than to improve patient health.

2.  Higher data quality.

            “Conclusions which are merely verbal cannot bear fruit, only those do which are based on demonstrated fact.”  – Hippocrates, Greek physician (460 BC – 377 BC)

The equation is simple: higher quality data means higher quality medical care.  One of the advantages of the digital age is the ability to synthesize huge amounts of data quickly.  However, the data used must be accurate.  Electronic health records are known to contain many errors, and patients can assure accuracy of their personal health data when they have access to check it.  With patient trust through data use transparency and data control comes more detailed and better data in, better and more accurate and precise conclusions out. 

3.  Bringing back fairness and balance to current industry-centric data monopolies.

“...while calling on the gods, a man should himself lend a hand.”  – Hippocrates, Greek physician (460 BC – 377 BC)

It is currently a data “gold rush” given current U.S. data and privacy regulations, and many large companies have made fortunes by making their customers into their commodity.  They sell consumer data non-transparently to unidentified entities that use the data for uncertain purposes with ambiguous ethics, creating a data economy with network effects favoring a few platforms able to collect and lock up the largest masses of personal data.  The data being recorded about a patient forms a remarkably detailed picture of their life. This picture is incredibly valuable when unified and stored both as a singularity and in conjunction with thousands, even millions of other lives.  These pictures reveal patterns that permits the personalization of medicine, insurance, finances and more but the question is, who owns and controls this valuable picture?  And what about the risks associated with massive data leaks through hacking and other data breaches?  Transparency and personal data controls are keys to creating a balanced and fair patient-centric digital data economy that promotes diverse and open competition.

4.  Assure patient access to their data.

A wise man ought to realize that health is his most valuable possession.”  – Hippocrates, Greek physician (460 BC – 377 BC)

Patient control of access to their own data is needed for a number of reasons.  First, it promotes data exchange across healthcare systems to assure access to critical health data wherever the patient may seek care.  Healthcare systems should be required to provide patients with their full medical record in electronic in a timely manner, and those systems who do not comply should be held accountable for data-blocking.  If we assure patients control their data, it will allow them to choose healthcare systems or associated third parties, thereby redistributing data across the economy to allow smaller companies, who may be more ethical and have better solutions, to compete.  In addition, patients could allow researchers access to their personal data.  Many researchers currently have trouble gaining access to data now in data silos created by industry purchases and other private sector agreements.  Researchers do not have access to big data needed to discover tomorrow’s cures and medical advancements.   Last, patients who are more engaged in their own healthcare tend to have better health outcomes overall, and patient data access allows patients to become more engaged in their own health.

5.  Preserve basic human rights.

“Wherever the art of medicine is loved, there is also a love of humanity.”  – Hippocrates, Greek physician (460 BC – 377 BC)

The “Right to Privacy” is a fundamental human right as declared by the UN Universal Declaration of Human Rights drafted after WWII that has been adopted around the world.  When this Declaration was adopted in 1948, the world had not yet imagined our new digital age.   Recently, however, some prominent leaders who remember the excesses of totalitarian regimes, have started to work to sharpen public opinion and remind us that our privacy is indeed a basic human right.  The right to privacy and control of data about our bodies is essential to preserving the dignity and respect of each individual, as well as trust in the medical community.  In the digital age, it will become the fiduciary duty of each doctor to protect the digital data privacy rights for each patient as a basic human right.

We are entering a new technological era for healthcare where we must commit to new standards of patient data privacy, data use transparency, and personal data control.  We have outlined five key reasons why this general topic is now more important than ever.  It will take many years of work on the part of academics, healthcare systems, industry, and government to fully assimilate all associated ethical, societal, technological, and business considerations to assure that we manage patient data in the right way.

Dr. Moira Schieke Bio
Founder and CEO of Cubismi, Dr. Moira Schieke is a cancer imaging clinical and research Radiologist based in Madison, WI.  Dr. Schieke completed her fellowship in cancer imaging at Dana Farber Cancer Institute in Boston, research fellowships at the National Institutes of Health in Bethesda, MD, and is adjunct Assistant Professor at the University of Wisconsin at Madison.  Dr. Schieke is a nationally recognized artist and painter. Cubismi was born of a critical need for cancer imaging innovation for earlier detection and better management of cancer.

Sanford Health and Good Samaritan close merger

Sanford Health and the Evangelical Lutheran Good Samaritan Society completed their merger, the organizations announced Wednesday.

Sanford, which has 45 hospitals, more than 1,300 physicians and 28,000 employees, adds Good Samaritan and its 200-plus post-acute, skilled-nursing, hospice, assisted-living, rehabilitation and home-health facilities to its network, along with Good Samaritan’s 19,000 employees. Their combined footprint spans 26 states.

The combination of the Sioux Falls, S.D.-based not-for-profits earned the necessary government approvals in August. Merger talks began in late 2017, when they started mapping out the integration process and growth opportunities, executives said.

David Horazdovsky remains CEO of Good Samaritan and has joined Sanford’s corporate leadership team. Randy Bury has transitioned to president of Good Samaritan from his previous role as Sanford’s chief administration officer.

“Wherever you combine acute-care operations with post-acute care you are going to find opportunities,” Kelby Krabbenhoft, president and CEO of Sanford Health, told Modern Healthcare.

Good Samaritan adds home and community-based services that can fill any gaps in care, Horazdovsky said.

“We see great growth opportunities,” he said.

The merger’s close is the latest transaction in an active post-acute sector as organizations and investors look to capitalize on the huge number of aging baby boomers. Coordinating care after patients leave the hospital is a key strategy for health systems that want to avoid health complications that can bring readmission penalties.

“The organization that can provide care in the most coordinated way will be the most successful—that is what we are shooting for,” Bury said.

Not-for-profit health system ProMedica expanded beyond its core business in its acquisition of struggling nursing home provider HCR ManorCare. Humana and private equity firms bought Kindred Healthcare and Curo Health to create the country’s largest hospice operator. LHC Group and Almost Family also combinedto form the second-largest home health provider in the country.

Consolidation is not expected to wane, experts said.

Sanford will continue to talk with other health systems about additional merger, acquisition or joint-venture opportunities as it looks to build out its long-term care operations, Krabbenhoft said. That marks a departure from the organization’s traditional focus on acute-care partnerships and acquisitions, he said.

“This moment today is an inflection point for the company as we are required as a function of our responsibility to now think about our facilities and operations like we never have before,” Krabbenhoft said.

From Modern Healthcare

Partners, Harvard Pilgrim table merger talks

Partners HealthCare and Harvard Pilgrim Health Care are tabling their planned merger after executives reportedly felt the deal was getting too complicated.

Boston-based Partners, Massachusetts’ dominant health system, and Wellesley, Mass.-based Harvard Pilgrim, the state’s second-largest health plan, announced in May they were considering a possible merger. On Friday, the not-for-profit companies confirmed the merger talks were on hold.

“Our discussions with Partners HealthCare have always been focused on exploring ways we can improve and enhance the patient experience while helping to control costs,” Harvard Pilgrim CEO Michael Carson said in a statement. “We continue to evaluate opportunities to collaborate with Partners on this important mission.”

Partners CEO Dr. David Torchiana told the Boston Globe the deal was getting too complicated and was bound to face regulatory scrutiny. He said the announcement doesn’t rule out the possibility of a future deal.

“I don’t think either organization is sure that it’s something that’s actually possible to achieve … in this environment right now where there’s such intense scrutiny of every move,” Torchiana told the newspaper.

Partners’ existing health plan, Neighborhood Health Plan, reported an operating loss of $5 million in the third quarter of 2018, compared with an operating gain of $34 million in the prior year period. NHP’s premium revenue dropped 64% during the quarter. Partners is rebranding the health plan, and beginning Jan. 1, will call it AllWays Health Partners.

Partners, whose hospitals include Brigham and Women’s Hospital and Massachusetts General Hospital, is still awaiting regulatory approval to acquire Care New England Health System of Providence, R.I.

Beth Israel Deaconess Medical Center and Lahey Health are still awaiting regulatory approval to form a health system they say will be large enough to compete with Partners. The combined entity would have 10 acute-care hospitals, compared with Partners’ eight, and would have three affiliate hospitals and more than 4,000 physicians.

The Massachusetts Health Policy Commission issued a highly critical report on that proposed deal in July. The report said the Beth Israel Deaconess-Lahey deal’s cost outweighed its benefits, and nothing would prevent the combined entity from raising prices, other than the state’s annual 3.1% cost growth limit.

In June, Harvard Pilgrim’s long-time CEO, Eric Schultz, abruptly resigned due to unspecified behavior he said violated the company’s code of conduct. A Harvard Pilgrim spokeswoman said the resignation didn’t affect its discussions with Partners.

John Hopkins Nurses Speak Out!

Nurses, Community Leaders to Discuss New Reports Documenting Johns Hopkins Hospital’s Failure to Provide Adequate Charity Care and Address Problems in Patient Care.

Johns Hopkins nurses will present three new reports documenting patient care concerns at the hospital and how these concerns extend far into the city of Baltimore at a town hall planned for Saturday, Dec. 1, 2018. The town hall, titled “Hopkins Nurses Speak Out!” will be held at the Reginald F. Lewis Museum of Maryland African-American History & Culture in Baltimore.

Also participating in the town hall will be Baltimore Councilmembers, Shannon Sneed, Kristerfer Burnett, Zeke Cohen, and Robert Stokes, Sr. as well as, Maryland Delegate Brooke Lierman. Reverend Marlon Tilghman, co-chair of Bridge Maryland, and Pastor of Ames United Methodist Church, Betty Robinson, community organizer and former Senior Research Coordinator at Johns Hopkins School of Public Health and Marisela Gomez, M.D., Ph.D., author and community organizer, will participate as community respondents to the report findings.

The new reports cover three main areas: A unit-by-unit survey of patient care conditions in the hospital, an analysis of Johns Hopkins tax exemptions and public rate support and the community benefits and charity care it provides in exchange, and an assessment of how the institution is responding to the ongoing problem of workplace violence.

What:  Town Hall featuring presentation of new reports on Johns Hopkins Hospital patient care and public accountability.

When: Saturday, Dec. 1, 10:30 a.m. – 12:30. p.m.

Where: Reginald F. Lewis Museum of Maryland African-American History & Culture, 830 E Pratt St., Baltimore. (Discounted parking available in garage at 815 E. Pratt Street.)

The reports, which will be available at the town hall and on request, include:

Foundations of Care:  Upholding the Legacy of Hopkins’ Nurse Pioneers

Johns Hopkins Hospital Patient Care Report – This report’s findings are based on a recent unit-by-unit survey conducted by nurses that work at Johns Hopkins Hospital. It flags chronic hospital-wide problems such as short and inappropriate staffing, high turnover, a lack of critical supplies, and shoddy equipment.

Breaking the Promise of Patient Care: How Johns Hopkins Hospital Management Shortchanges Baltimore and Puts Patients and the Community at Risk – This report, produced by researchers from National Nurses United and the AFL-CIO, documents that the hospital receives far more in annual tax exemptions and public rate support than it provides in charity care and community benefits, despite the tremendous need for both in the communities surrounding the hospital.

Nurses at Risk: Insufficient Protections at Johns Hopkins Hospital Compromise Nurse and Patient Health and Safety – This report reveals the institution’s failure to adopt robust policies to prevent and respond to workplace violence and how this undermines and endangers patients and nurses.

“We are very excited to share and discuss the report findings with our community,” said Kimberly Henriquez, RN, Oncology. “They reveal a wide discrepancy between the image the institution projects, and what’s really going on day-to-day, unit-by-unit. Nurses are organizing to close that gap so that our patients and our community get the care they deserve.

“We are inviting nurses and the wider community to come to the town hall so that together we can hold Johns Hopkins Hospital accountable to its founder’s vision and to the community he meant it to serve,” said Annie Embertson, RN. Endoscopy. “We are inspired by the legacy of Hopkins’ own nurse pioneers who showed us that to be effective patient advocates we absolutely must speak out.”

Megan Callahan Will Head up Lyft’s Health Care Efforts

After a months-long search, Lyft has hired a leader for its growing health care business, which helps patients get rides to non-emergency medical appointments. The company is set to announce it’s hired Megan Callahan, formerly the chief strategy officer for Change Healthcare, a company that merged with McKesson in 2017, as its health lead.

The hire comes as Lyft is looking to ramp up revenues ahead of a possible IPO 2019. The company’s chief business officer David Baga told CNBC by phone that health represents a “sizable chunk” of Lyft Business, which is set to achieve a annualized revenue run rate of $1 billion by the end of the year. Lyft told CNBC that the number of health care rides tripled from the third quarter of 2017 to the same period a year later.

Lyft’s primary competitor, Uber, also views health as a growth opportunity. Both companies have built out dedicated teams in health, and have formulated a strategy to work with stakeholders in the industry to help patients who need help to get to the doctor’s office on time.

Non-emergency medical transportation is attractive for both ride-sharing companies because insurers, including some Medicaid and Medicare plans, will often cover the cost of the ride for patients. There’s a huge incentive for health plans to make transportation easier, as studies have found that a lack of transportation is a key reason why patients avoid the doctor’s office.

Lyft’s focus is to forge partnerships in health care with traditional players, including health systems, medical transportation brokers and health IT companies. For instance, in March it signed an exclusive deal with medical record technology provider Allscripts to make it easier for doctors to book Lyft rides for their patients.

To that end, Baga, the chief business officer, told CNBC it needed to hire an operator from the industry to maintain and build on these relationships.

“We wanted someone for the job who lives and breathes health care,” he explained. “But we also wanted someone who could understand the key challenges, and be willing to break from the status quo.”

Callahan told CNBC she joined Lyft because of the opportunity to improve access to health care services, particularly for low-income or elderly users.

She also said that Lyft’s deep knowledge about health stood out relative to other technology players.

“I was gobsmacked by the level of understanding on HIPAA and PHI,” she said, referring to the complex web of federal privacy rules and regulations that govern how health data is stored and shared. “They (Lyft) had clearly taken the time to understand the industry.”

Lyft is also moving into other areas, including working with pharmaceutical companies to people get to clinical trial sites and arranging rides for physical therapists to treat patients in their homes.

Experts say that’s the tip of the iceberg for Lyft and other new transportation entrants.

“There’s home care, there’s delivery of goods and supplies — it becomes a market in the tens of billions of dollars if you’re looking at logistics opportunities in health care,” said John Brownstein, co-founder of a company in the space called Circulation Health that partners with Lyft. Circulation was recently acquired by one of the largest brokers in the space, Logisticare.

Callahan didn’t rule out any of these sorts of opportunities, but said her near-term goal was to look for more ways to increase rides and reduce missed appointments.

Athenahealth sold to Veritas Capital for $5.7 billion

Athenahealth has agreed to be acquired by a Veritas Capital and Evergreen Coast Capital affiliate for $5.7 billion, the companies announced Monday morning.

Athenahealth will continue to be its own brand, but Veritas and Evergreen will merge it with Virence Health, the analytics and software firm formerly known as the Value-Based Care Solutions Group, which GE Healthcare acquired earlier in 2018.

Virence Chairman and CEO Bob Segert will lead the newly combined company.

“Combining with Virence will create new opportunities for collaboration and growth,” Athenahealth Executive Chairman Jeff Immelt said in a statement.

Athenahealth has been facing takeover attempts since at least 2017, when Elliott Management first tried to buy the company. Elliott Management supports the Veritas-Evergreen acquisition. The transaction “represents an outstanding, value-maximizing outcome for Athenahealth shareholders,” Elliott partner Jesse Cohn said in a statement.

Athenahealth will hold an earnings call later Monday. In a third-quarter earnings report released Friday, the company reported it booked less business compared to the same period of 2017. Revenue for the quarter was $329.5 million, according to the company’s new accounting standards, and $331.4 million according to the old standards, up 9% over the year-before quarter.

Athenahealth’s stock was up nearly 10%, to $131.97 a share at the end of trading Monday.